To recover your password please fill in your email address
Please fill in below form to create an account with us
Kate Wilson is the CTC’s Research Development Manager, supporting the exploration and development of new clinical trials at the CTC. Since 2004 she has played a key role in the development and conduct of investigator initiated clinical trials sponsored by the AGITG and conducted by the CTC. Kate’s research themes are oncology, COVID-19 and new therapeutic area collaborations.
She is co-author on more than 25 AGITG/CTC trial publications which reflect her interest in the field of gastro-intestinal oncology clinical research and the ability to contribute to cancer collaborative group research on a national and international level.
Kate led the development activities for the BEAT COVID-19 study, a bayesian adaptive platform study treating people in the community with COVID-19 in NSW.
In her Research Development Manager role Kate supports at team of Research Development Leads who work with cancer collaborative groups based at the CTC to develop new research to be conducted in collaboration with the CTC.
In addition as part the business and research development role Kate meets with new researchers and research groups from a range of therapeutic areas to explore potential academic collaborations and new business development with researchers at the CTC.
Kate is also an experienced medical and grant writer and provides leadership to staff preparing grant applications and works closely with external collaborators to secure funding for clinical trials coordinated by the CTC.